Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD

Journal of Lipid Research

Volumn 50, Issue 9, 2009, Pages 1927-1935

  Matthan, Nirupa R ^a   Pencina, Michael ^b   LaRocque, Jane M ^a   Jacques, Paul F ^a   D'Agostino, Ralph B ^b   Schaefer, Ernst J ^a   Lichtenstein, Alice H ^a  

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Campesterol; Coronary heart disease; Desmosterol; Lathosterol; Lipids; Lipoproteins; Phytosterols; Sitosterol

Indexed keywords

CAMPESTEROL; CHOLESTANOL; DESMOSTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SITOSTEROL; TRIACYLGLYCEROL;

ABSORPTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CHOLESTEROL ABSORTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL HOMEOSTASIS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ABSORPTION; AGED; BIOLOGICAL MARKERS; CAROTID STENOSIS; CASE-CONTROL STUDIES; CHOLESTANOL; CHOLESTEROL; CORONARY ARTERY DISEASE; DIET; FAMILY; FEMALE; HOMEOSTASIS; HUMANS; MALE; MASSACHUSETTS; PHYTOSTEROLS;

EID: 70350371463     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P900039-JLR200     Document Type: Article

References (48)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 106: 3143-3421.
2. Baigent, C., A. Keech, P. M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, et al. for Cholesterol Treatment Trialists' (CTT) Collaborators. 2005. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet. 366: 1267-1278.
3. Heart Protection Study Collaborative Group. 2002. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 360: 23-33.
4. Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. 1998. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N. Engl. J. Med. 339: 1349-1357.
5. Nakamura, H., K. Arakawa, H. Itakura, A. Kitabatake, Y. Goto, T. Toyota, N. Nakaya, S. Nishimoto, M. Muranaka, A. Yamamoto, et al. MEGA Study Group. 2006. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial. Lancet. 368: 1155-1163.
6. Sacks, F. M., M. A. Pfeffer, L. A. Moye, J. L. Rouleau, J. D. Rutherford, T. G. Cole, L. Brown, J. W. Warnica, J. M. Arnold, C. C. Wun, et al. 1996. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med. 335: 1001-1009.
7. Scandinavian Simvastatin Survival Study Group. 1994. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 344: 1383-1389.
8. Thavendiranathan, P., A. Bagai, M. A. Brookhart, and N. K. Choudhry. 2006. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 166: 2307-2313.
9. West of Scotland Coronary Prevention Study Group. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 333: 1301-1307.
10. Genest, J., Jr., J. R. McNamara, J. M. Ordovas, J. L. Jenner, S. R. Silberman, K. M. Anderson, P. W. Wilson, D. N. Salem, and E. J. Schaefer. 1992. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J. Am. Coll. Cardiol. 19: 792-802.
11. Scandinavian Simvastatin Survival Study Writing Group. 1995. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet. 345: 1274-1275.
12. Kruit, J. K., A. K. Groen, T. J. van Berkel, and F. Kuipers. 2006. Emerging roles of the intestine in control of cholesterol metabolism. World J. Gastroenterol. 12: 6429-6439.
13. Dawson, P. A., and L. L. Rudel. 1999. Intestinal cholesterol absorption. Curr. Opin. Lipidol. 10: 315-320.
14. Matthan, N. R., and A. H. Lichtenstein. 2004. Approaches to measuring cholesterol absorption in humans. Atherosclerosis. 174: 197-205.
15. Santosa, S., K. A. Varady, S. AbuMweis, and P. J. H. Jones. 2007. Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist? Life Sci. 80: 505-514.
16. Kesaniemi, Y. A., and T. A. Miettinen. 1987. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur. J. Clin. Invest. 17: 391-395.
17. Miettinen, T. A., R. S. Tilvis, and Y. A. Kesaniemi. 1990. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am. J. Epidemiol. 131: 20-31.
18. Kuksis, A. 2001. Plasma non-cholestrol sterols. J. Chromatogr. A. 935: 203-236.
19. Bjorkhem, I., T. Miettinen, E. Reihner, S. Ewerth, B. Angelin, and K. Einarsson. 1987. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J. Lipid Res. 28: 1137-1143.
20. Matthan, N. R., M. Raeini-Sarjaz, A. H. Lichtenstein, L. M. Ausman, and P. J. H. Jones. 2000. Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women. Lipids. 35: 1037-1044.
21. Feinleib, M., W. B. Kannel, R. J. Garrison, P. M. McNamara, and W. P. Castelli. 1975. The Framingham Offspring Study: design and preliminary data. Prev. Med. 4: 518-525.
22. Dawber, T. R., G. F. Meadors, and F. Moore. 1951. Epidemiological approaches to heart disease: the Framingham Study. Am. J. Public Health. 41: 279-286.
23. Kannel, W. B., M. Feinleib, P. M. McNamara, R. J. Garrison, and W. P. Castelli. 1979. An investigation of coronary heart disease in families. The Framingham offspring study. Am. J. Epidemiol. 110: 281-290.
24. Rimm, E. B., E. L. Giovannucci, M. J. Stampfer, G. A. Colditz, L. B. Litin, and W. C. Willett. 1992. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am. J. Epidemiol. 135: 1114-1126.
25. Willett, W. C., L. Sampson, M. J. Stampfer, B. Rosner, C. Bain, J. Witschi, C. H. Hennekens, and F. E. Speizer. 1985. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am. J. Epidemiol. 122: 51-65.
26. McNamara, J. R., and E. J. Schaefer. 1987. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin. Chim. Acta. 166: 1-8.
27. Warnick, G. R., J. Benderson, and J. J. Albers. 1982. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
28. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
29. Matthan, N. R., A. Giovanni, E. J. Schaefer, B. G. Brown, and A. H. Lichtenstein. 2003. Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. J. Lipid Res. 44: 800-806.
30. Nissinen, M. J., H. Gylling, and T. A. Miettinen. 2008. Responses of surrogate markers of cholesterol absorption and synthesis to changes in cholesterol metabolism during various amounts of fat and cholesterol feeding among healthy men. Br. J. Nutr. 99: 370-378.
31. Assmann, G., P. Cullen, J. Erbey, D. R. Ramey, F. Kannenberg, and H. Schulte. 2005. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr. Metab. Cardiovasc. Dis. 16: 13-21.
32. Rajaratnam, R. A., H. Gylling, and T. A. Miettinen. 2000. Independent association of serum squalene and non-cholesterol sterols with coronary artery disease in postmenopausal women. J. Am. Coll. Cardiol. 35: 1185-1191.
33. Sutherland, W. H. F., M. J. A. Willaims, E. R. Nye, N. J. Restieaux, S. A. de Jong, and H. L. Walker. 1998. Association of plasma non-cholesterol sterol levels with severity of coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 8: 386-391.
34. Glueck, C. J., J. Speirs, T. Tracy, P. Streicher, E. Illig, and J. Vandegrift. 1991. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism. 40: 842-848.
35. Sudhop, T., D. Lutjohann, M. Agna, C. von Ameln, W. Prange, and K. von Bergmann. 2003. Comparison of the effects of sitostanol, sitostanol acetate, and sitostanol oleate on the inhibition of cholesterol absorption in normolipemic healthy male volunteers. A placebo controlled randomized cross-over study. Arzneimittelforschung. 53: 708-713.
36. Pinedo, S., M. N. Vissers, K. von Bergmann, K. Elharchaoui, D. Lutjohann, R. Luben, N. J. Wareham, J. J. P. Kastelein, K-T. Khaw, and S. M. Boekholdt. 2007. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk population study. J. Lipid Res. 48: 139-144.
37. Wilund, K. R., L. Yu, F. Xu, G. L. Vega, S. M. Grundy, J. C. Cohen, and H. H. Hobbs. 2004. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler. Thromb. Vasc. Biol. 24: 2326-2332.
38. Fassbender, K., D. Lutjohann, M. G. Dik, M. Bremmer, J. Konig, S. Walter, Y. Liu, M. Letiembre, K. Von Bergmann, and C. Jonker. 2008. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-the LASA study. Atherosclerosis. 196: 283-288.
39. Thiery, J., U. Ceglarek, G. M. Fiedler, A. Leichtle, S. Baumann, D. Teupser, O. Lang, J. Baumert, C. Meisinger, H. Loewel, et al. 2006. Elevated campesterol serum levels: a significant predictor of incident myocardial infarction: results of the population-based MONICA/KORA follow-up study 1994 to 2005. Circ. Suppl. 114: Abs. 4099.
40. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA. 285: 2486-2497.
41. Gylling, H., and T. A. Miettinen. 1996. Cholesterol absorption and lipoprotein metabolism in type II diabetes mellitus with and without coronary artery disease. Atherosclerosis. 126: 325-332.
42. Gylling, H., and T. A. Miettinen. 1997. Cholesterol absorption, synthesis and LDL metabolism in NIDDM. Diabetes Care. 20: 90-95.
43. Briones, E. R., D. L. Steiger, P. J. Palumbo, W. M. O'Fallon, A. L. Langworthy, B. R. Zimmerman, and B. A. Kottke. 1986. Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia. Am. J. Clin. Nutr. 44: 353-361.
44. Sutherland, W. H., R. S. Scott, C. J. Lintott, M. C. Robertson, S. A. Stapely, and C. Cox. 1992. Plasma non-cholestrol sterols in patients with non-insulin dependent diabetes mellitus. Horm. Metab. Res. 24: 172-175.
45. Simonen, P., H. Gylling, A. N. Howard, and T. Miettinen. 2000. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am. J. Clin. Nutr. 72: 82-88.
46. Anderson, G. H., and D. Woodend. 2003. Effect of glycemic carbohydrates on short-term satiety and food intake. Nutr. Rev. 61: S17-S26.
47. Rajaratnam, R. A., H. Gylling, and T. A. Miettinen. 2001. Cholesterol absorption, synthesis, and fecal output in postmenopausal women with and without coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 21: 1650-1655.
48. Berge, K. E., K. von Bergmann, D. Lutjohann, R. Guerra, S. M. Grundy, H. H. Hobbs, and J. C. Cohen. 2002. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J. Lipid Res. 43: 486-494.